Home › Glioblastoom › Californië › San Francisco
Glioblastoom klinische studies in San Francisco, CA
17 studies voor Glioblastoom zoeken deelnemers op locaties in en rond San Francisco (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
RekruterenFase 3
- Sutter Health - California Pacific Medical Center, San Francisco
- University of California, San Francisco, San Francisco
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
RekruterenFase 1
- University of California San Francisco, San Francisco
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
RekruterenFase 1/2
- UCSF Helen Diller Medical Center at Parnassus Heights - Neurology, San Francisco
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RekruterenFase 3
- University of California, San Francisco
Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells
RekruterenFase 1
- University of California, San Francisco, San Francisco
A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
RekruterenFase 2
- University of California, San Francisco, San Francisco
A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial
RekruterenFase 2
- University of California, San Francisco, San Francisco
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
RekruterenFase 2
- UCSF, San Francisco
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
RekruterenFase 1
- University of California, San Francisco, San Francisco
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Rekruteren
- Zuckerberg San Francisco General, San Francisco
- Kaiser Foundation Research Institute, San Francisco
- University of San Francisco, San Francisco
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RekruterenFase 1/2
- University of California at San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, San Francisco
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
RekruterenObservatieonderzoek
- University of California, San Francisco, San Francisco
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
RekruterenObservatieonderzoek
- University of California, San Francisco (UCSF), San Francisco
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
RekruterenObservatieonderzoek
- University of California, San Francisco, San Francisco
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
RekruterenObservatieonderzoek
- University of California, San Francisco, San Francisco
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
RekruterenObservatieonderzoek
- University of California, San Francisco, San Francisco
Glioblastoom studies in andere steden
- New York City, NY30 studies
- Boston, MA28 studies
- Houston, TX26 studies
- Los Angeles, CA24 studies
- Durham, NC20 studies
- Chicago, IL15 studies
- Washington, DC15 studies
- Columbus, OH14 studies
- Miami, FL14 studies
- Rochester, MN13 studies
- Jacksonville, FL13 studies
- Aurora, CO12 studies
Andere studies in San Francisco
- Prostaatkanker45 studies
- Borstkanker43 studies
- Niet-kleincellige longkanker36 studies
- Kanker (alle vormen)35 studies
- Hartfalen29 studies
- Metastatische kanker28 studies
- Longkanker22 studies
- Melanoom22 studies
- Aldermeesklierkanker20 studies
- Eierstokkanker19 studies
- Colorectale kanker18 studies
- Cardiovasculaire ziekte18 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.